MAZ and cancer: Given the effects of panobinostat in reducing cell proliferation (Table 1 and Figure 4), we set out to test if this phenomenon was sustained by the master regulators most consistently repressed by this treatment; namely, the TFs BAZ1A, HCHFC1, MAZ, and ZNF146, which are also associated with poor prognosis in both NBL and pan-cancer (TCGA) datasets.